Abstract
Highly active antiretroviral therapy (HAART) confers several benefits,including reduction in viral load and longevity in HIV positive patients.However, Metabolic and morphological complications have been increasingly reported among patients in the advanced industrialized countries receiving chronic HAART up to 10-20years. We report occurrence of hyperlipidaemia in subjects on HAART in a West African Community. The CD4+ cell count and fasting lipid profile were estimated in One hundred and ten (110) HIV positive patients attending the HIV clinic of Obafemi Awolowo College of Health Sciences, Sagamu. Fifty five subjects served as the study subjects and were selected randomly from the patients on triple combination therapy of ARV medication for a minimum of 3 years and matched for age and sex with the control group (55) of those who were not on ARV medication. All the subjects were symptomatic grade 3 or 4 WHO classification. The CD4 count of the study was 355.11cells/mm3+ 185.0 and was statistically significantly higher than the CD4 count of the control subjects which was 177.95 cells/mm3 + 59.1 (P200mg/dl) was 15%.in the study group and 2.5%.in the control. (Afr. J. Biomed. Res. 11: 27 -31)Key words: dyslipidaemia, limited resource settings, hypertryglyceremia,hypercholesteremia, HAART, lipid concentration
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
